ATAI Life Sciences N.V.·4

Jan 3, 4:30 PM ET

Kochendoerfer Gerd 4

4 · ATAI Life Sciences N.V. · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Kochendoerfer Gerd
Chief Operating Officer
Transactions
  • Award

    Stock Option

    2025-01-02+1,450,0001,450,000 total
    Exercise: $1.60Exp: 2035-01-01Common Shares (1,450,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest as to 25% on December 3, 2025 and in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4